MEP20908A - Thienopyrazoles - Google Patents

Thienopyrazoles

Info

Publication number
MEP20908A
MEP20908A MEP-209/08A MEP20908A MEP20908A ME P20908 A MEP20908 A ME P20908A ME P20908 A MEP20908 A ME P20908A ME P20908 A MEP20908 A ME P20908A
Authority
ME
Montenegro
Prior art keywords
thienopyrazoles
altered
inhibition
compounds
preparation
Prior art date
Application number
MEP-209/08A
Other languages
Bosnian (bs)
English (en)
Unknown language (me)
Inventor
John Gerard Jurcak
Matthieu Barrague
Timothy Alan Gillespy
Michael Louis Edwards
Kwon Yon Musick
Philip Marvin Weintraub
Yan Du
Ramalinga M Dharanipragada
Ashfaq Ahmed Parkar
Original Assignee
Aventis Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Inc filed Critical Aventis Pharma Inc
Publication of MEP20908A publication Critical patent/MEP20908A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
MEP-209/08A 2003-09-08 2004-07-23 Thienopyrazoles MEP20908A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US50115903P 2003-09-08 2003-09-08
PCT/US2004/023814 WO2005026175A1 (fr) 2003-09-08 2004-07-23 Thienopyrazoles

Publications (1)

Publication Number Publication Date
MEP20908A true MEP20908A (en) 2010-06-10

Family

ID=34312256

Family Applications (1)

Application Number Title Priority Date Filing Date
MEP-209/08A MEP20908A (en) 2003-09-08 2004-07-23 Thienopyrazoles

Country Status (29)

Country Link
US (2) US7518000B2 (fr)
JP (1) JP4879739B2 (fr)
KR (1) KR20060069490A (fr)
CN (1) CN100398545C (fr)
AT (1) ATE468341T1 (fr)
AU (1) AU2004272507B2 (fr)
BR (1) BRPI0414215A (fr)
CA (1) CA2538032C (fr)
CR (1) CR8255A (fr)
DE (1) DE602004027288D1 (fr)
DK (1) DK1682553T3 (fr)
EC (1) ECSP066411A (fr)
ES (1) ES2345257T3 (fr)
HR (1) HRP20100398T1 (fr)
IL (1) IL173916A (fr)
MA (1) MA28038A1 (fr)
ME (1) MEP20908A (fr)
MX (1) MXPA06001827A (fr)
MY (1) MY144339A (fr)
NO (1) NO20061626L (fr)
NZ (1) NZ545421A (fr)
OA (1) OA13252A (fr)
PT (1) PT1682553E (fr)
RS (2) RS51846B (fr)
RU (1) RU2358978C2 (fr)
TN (1) TNSN06058A1 (fr)
TW (1) TWI352705B (fr)
WO (1) WO2005026175A1 (fr)
ZA (1) ZA200601947B (fr)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006101454A1 (fr) * 2005-03-21 2006-09-28 S*Bio Pte Ltd Derives du benzothiophene: preparation et applications pharmaceutiques
WO2007076228A2 (fr) * 2005-12-20 2007-07-05 Boehringer Ingelheim International Gmbh Inhibiteurs de kinases tec
EP2151434A1 (fr) 2008-08-05 2010-02-10 Institut Pasteur Alkoxypyrazoles et leur procédé de préparation
EP2151433A1 (fr) 2008-08-05 2010-02-10 Institut Pasteur Alkoxypyrazoles et leur procédé de préparation
US8299070B2 (en) 2009-11-25 2012-10-30 Japan Tobacco Inc. Indole compounds and pharmaceutical use thereof
US20130158066A1 (en) * 2011-12-20 2013-06-20 Hoffmann-La Roche Inc. 4-azaindole inhibitors of crac
WO2013153539A1 (fr) 2012-04-13 2013-10-17 Glenmark Pharmaceuticals S.A. Composés tricycliques à titre d'inhibiteurs de kinases tec
CN103467481B (zh) * 2012-06-07 2016-08-31 上海汇伦生命科技有限公司 二氢吡啶类化合物、其组合物、制备方法和用途
UY34893A (es) 2012-07-10 2014-02-28 Takeda Pharmaceutical Derivados de azaindol
WO2014041518A1 (fr) * 2012-09-14 2014-03-20 Glenmark Pharmaceuticals S.A. Composés thiénopyrrole comme inhibiteurs de l'itk
CN103720694A (zh) * 2012-10-11 2014-04-16 韩冰 一类治疗脑性瘫痪的化合物及其用途
CN103772391A (zh) * 2012-10-23 2014-05-07 杨子娇 一类治疗房角狭窄的化合物及其用途
KR101571590B1 (ko) * 2012-11-21 2015-11-25 주식회사 두산 유기 화합물 및 이를 이용하는 유기 전계 발광 소자
CN111265531B (zh) 2013-10-25 2023-11-10 药品循环有限责任公司 治疗和预防移植物抗宿主病的方法
AR099052A1 (es) 2014-01-09 2016-06-29 Takeda Pharmaceuticals Co Derivados de azaindol
WO2016010108A1 (fr) * 2014-07-18 2016-01-21 塩野義製薬株式会社 Dérivés hétérocycliques contenant de l'azote et compositions médicinales le contenant
MX2018002554A (es) 2015-08-31 2018-08-14 Pharmacyclics Llc Combinaciones de inhibidores de btk para tratar mieloma multiple.
MA46783A (fr) 2016-11-03 2019-09-11 Juno Therapeutics Inc Polythérapie de type thérapie cellulaire t et inhibiteur de btk
JP7410877B2 (ja) 2018-05-03 2024-01-10 ジュノー セラピューティクス インコーポレイテッド キメラ抗原受容体（ｃａｒ）ｔ細胞療法とキナーゼ阻害剤の併用療法
WO2023139248A1 (fr) * 2022-01-21 2023-07-27 Ecole Polytechnique Federale De Lausanne (Epfl) Inhibiteurs de thioestérases de protéine acyle contre des infections microbiennes
US20250302954A1 (en) 2022-05-11 2025-10-02 Celgene Corporation Methods to overcome drug resistance by re-sensitizing cancer cells to treatment with a prior therapy via treatment with a t cell therapy
WO2024123175A1 (fr) 2022-12-06 2024-06-13 Erasmus University Medical Center Rotterdam Compositions pour le traitement de cancers résistants à la thérapie par blocage de point de contrôle immunitaire

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5654307A (en) * 1994-01-25 1997-08-05 Warner-Lambert Company Bicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family
US6462036B1 (en) * 1998-11-06 2002-10-08 Basf Aktiengesellschaft Tricyclic pyrazole derivatives
US6297238B1 (en) * 1999-04-06 2001-10-02 Basf Aktiengesellschaft Therapeutic agents
KR100718830B1 (ko) * 1999-06-23 2007-05-17 사노피-아벤티스 도이칠란트 게엠베하 치환된 벤즈이미다졸 및 이의 제조방법
YU54202A (sh) * 2000-01-18 2006-01-16 Agouron Pharmaceuticals Inc. Jedinjenja indazola, farmaceutske smeše i postupci za stimulisanje i inhibiranje ćelijske proliferacije
US7101884B2 (en) * 2001-09-14 2006-09-05 Merck & Co., Inc. Tyrosine kinase inhibitors
JP5039268B2 (ja) * 2001-10-26 2012-10-03 アベンティス・ファーマスーティカルズ・インコーポレイテツド ベンゾイミダゾールおよび類縁体および蛋白キナーゼ阻害剤としてのその使用
FR2831536A1 (fr) * 2001-10-26 2003-05-02 Aventis Pharma Sa Nouveaux derives de benzimidazoles, leur procede de preparation, leur application a titre de medicament, compositions pharmaceutiques et nouvelle utilisation notamment comme inhibiteurs de kdr

Also Published As

Publication number Publication date
NO20061626L (no) 2006-04-10
ATE468341T1 (de) 2010-06-15
US7518000B2 (en) 2009-04-14
CN1849322A (zh) 2006-10-18
RS51846B (sr) 2012-02-29
RU2358978C2 (ru) 2009-06-20
ZA200601947B (en) 2007-05-30
CR8255A (es) 2006-07-14
AU2004272507B2 (en) 2011-05-12
KR20060069490A (ko) 2006-06-21
BRPI0414215A (pt) 2006-11-07
CA2538032C (fr) 2011-01-11
US20070254937A1 (en) 2007-11-01
CA2538032A1 (fr) 2005-03-24
PT1682553E (pt) 2010-07-29
JP2007505038A (ja) 2007-03-08
RS20060162A (sr) 2008-06-05
TWI352705B (en) 2011-11-21
WO2005026175A1 (fr) 2005-03-24
AU2004272507A1 (en) 2005-03-24
OA13252A (en) 2007-01-31
HRP20100398T1 (hr) 2010-09-30
NZ545421A (en) 2010-03-26
ECSP066411A (es) 2006-09-18
JP4879739B2 (ja) 2012-02-22
US20100056514A1 (en) 2010-03-04
IL173916A0 (en) 2006-07-05
DE602004027288D1 (en) 2010-07-01
RU2006111470A (ru) 2007-10-27
TW200519118A (en) 2005-06-16
US7928231B2 (en) 2011-04-19
IL173916A (en) 2011-07-31
TNSN06058A1 (en) 2007-10-03
MA28038A1 (fr) 2006-07-03
ES2345257T3 (es) 2010-09-20
DK1682553T3 (da) 2010-08-23
MXPA06001827A (es) 2006-05-31
CN100398545C (zh) 2008-07-02
HK1095587A1 (zh) 2007-05-11
MY144339A (en) 2011-08-29

Similar Documents

Publication Publication Date Title
CY1122336T1 (el) Eνωσεις πυρρολιου ως αναστολεις πρωτεϊνικων κινασων εrκ και φαρμακευτικες συνθεσεις που περιεχουν αυτες τις ενωσεις
ATE466580T1 (de) Azolylaminoazine als proteinkinasehemmer
ATE468336T1 (de) Azolylaminoazine als proteinkinasehemmer
ATE365733T1 (de) Zusammensetzungen brauchbar als protein-kinase- inhibitoren
DE602006004844D1 (de) Pyrrolopyrimidine verwendbar als protein kinase inhibitoren
ATE450530T1 (de) Zusammensetzungen zur verwendung als protein- kinase-inhibitoren
ATE433973T1 (de) Azolylaminoazine als inhibitoren von proteinkinasen
CY1111599T1 (el) Αναστολεις κινασης θειενοπυριδινης και φουροπυριδινης
DE602004014117D1 (de) Thiazole zur verwendung als inhibitoren von protein-kinasen
BRPI0509369A (pt) azaindóis úteis como inibidores de jak e outras proteìna cinases
BR0316350A (pt) Diaminotriazóis úteis como inibidores de proteìna cinases
EA200700886A1 (ru) Соединение тиадиазола и его применение
DK1347971T3 (da) Thiazolylinhibitorer af tyrosinkinaser fra Tec-familien
EE200300475A (et) Türosiini kinaasi inhibiitorid, neid sisaldavad ravimkoostised ja nimetatud ühendid kasutamiseks haiguste ravis
DK1682553T3 (da) Thienopyrazoler
NO20082508L (no) Aminopyrimidiner anvendelige som kinaseinhibitorer
CY1110965T1 (el) Επιπροσθετες ετεροπολυκυκλικες ενωσεις και η χρηση τους ως ανταγωνιστες μεταβολοτροπικου υποδοχεα γλουταμικου
NO20071875L (no) Bicykliske amider som kinaseinhibitorer
HRP20050967A2 (en) Pyrazolo-quinazoline derivatives, process for their preparation and their use as kinase inhibitors
ATE464303T1 (de) Als inhibitoren von rock und anderen proteinkinasen geeignete zusammensetzungen
ATE482213T1 (de) Als inhibitoren von proteinkinasen geeignete pyrazoloä1,5-aüpyrimidine
HRP20050826B1 (hr) Ciklički inhibitori proteinske tirozin kinaze
ATE548363T1 (de) 3,5-disubstituierte pyrid-2-one, die sich als inhibitoren der tec-familie von nicht-rezeptor- tyrosinkinasen eignen
CO5660287A2 (es) Derivados de tetrahidrocarbazol y su uso farmaceutico
IL179206A0 (en) Pyrrolylpyrimidine derivatives and pharmaceutical compositions containing the same